John H. Kempen, MD, MPH, PhD, MHS, will be honored with the 2020 Outstanding Humanitarian Service Award from the American Academy of Ophthalmology (AAO) during the annual meeting in November. The award recognizes Dr. Kempen’s deep commitment to charitable work that aims to reduce blindness worldwide by improving access to patient care and establishing much-needed ophthalmology sub-specialty training programs in developing countries.... Read more about John H. Kempen, MD, MPH, PhD, MHS to Receive Outstanding Humanitarian Service Award

After seven years, multi-center clinical trial finds systemic therapy better preserves visual acuity and has fewer side effects 

Boston, Mass. — Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a long-lasting corticosteroid intraocular implant, according to a clinical trial funded by the National Eye Institute (NEI). After seven years, visual acuity on average remained stable among participants on systemic therapy but...